<DOC>
	<DOCNO>NCT00694759</DOCNO>
	<brief_summary>The purpose study determine insulin resistance ( well body use insulin clear sugar ) affect cortisol level normal healthy woman woman polycystic ovary syndrome body weight .</brief_summary>
	<brief_title>Cortisol Regulation Polycystic Ovary Syndrome ( PCOS )</brief_title>
	<detailed_description>PCOS common clinical problem affect young woman , characterize oligomenorrhea hyperandrogenism . Central obesity insulin resistance also prominent feature PCOS , addition important risk factor development hypertension , hyperlipidemia atherosclerotic heart disease . Previous study suggest cortisol dysregulated PCOS , primarily increase hypothalamic-pituitary-adrenal ( HPA ) axis activity enhance cortisol secretion . Increased adrenocorticotropic hormone ( ACTH ) secretion could also potentially lead elevate adrenal androgen production PCOS . Techniques use previous study inconsistent , however , link increase HPA axis activity phenotypic change PCOS clearly demonstrate . Cortisol also produce cortisone peripheral adipose tissue enzyme 11beta-hydroxysteroid dehydrogenase type 1 ( HSD 1 ) , suggest another potential point dysregulation may contribute central obesity insulin resistance PCOS . Further investigation central peripheral regulation cortisol necessary good understand pathophysiology PCOS . Specific Aim 1 : To perform cross-sectional study woman PCOS normal control match age body mass index , measure insulin sensitivity visceral fat , well ( ) 24-hour CPR , ACTH , free cortisol , cortisol binding globulin ( CBG ) , ( b ) adipocyte , liver , whole body HSD 1 activity , ( c ) androgen level . Specific Aim 2 : To prospectively administer pioglitazone metformin woman PCOS placebo-controlled trial , one month six month therapy measure ( ) 24-hour CPR , ACTH , free cortisol , CBG , ( b ) adipocyte , liver , whole body HSD 1 activity , ( c ) insulin sensitivity , visceral fat , androgen level .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Inclusion Criteria ( Healthy control ) : Healthy At lifetime maximal weight Weight stable least 6 month prior study entry Willing commit make significant change diet daily activity enrol . Premenopausal Have regular menstrual cycle No evidence hirsutism Additional Inclusion Criteria ( Subjects PCOS ) : Clinical finding amenorrhea oligomenorrhea date menarche Clinical and/or biochemical evidence hyperandrogenism Exclusion relate disorder Exclusion Criteria ( Healthy control ) : Less 18 year age Exercise &gt; 30 minutes/day , 3 time week Smokers Heavy alcohol drinker ( &gt; 2 drinks/day ) Type 2 diabetes Medical diagnosis include heart disease cancer Psychiatric illness ( i.e.depression , psychosis , bipolar , schizophrenia ) Body weight &gt; 136 kg Pregnant Endocrine diseases affect body composition androgen level Additional Exclusion Criteria ( Subjects PCOS ) : Laboratory evidence hyperprolactinemia , thyroid dysfunction , 21hydroxylasedeficient nonclassic CAH Contraindication pioglitazone ( i.e . CHF , impair liver function , anemia , depress leukocyte count , pulmonary disease , know sensitivity thiazolidinediones .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Polycystic ovary syndrome</keyword>
	<keyword>insulin</keyword>
	<keyword>PCOS</keyword>
	<keyword>cortisol regulation</keyword>
	<keyword>regulation</keyword>
</DOC>